Recently, Toska et al. demonstrated the cooperative interplay of FOXA1, PBX1, and the histone methyltransferase KMT2D, in the adaptive response of ER+ breast cancer to PI3K inhibition52. Here, PRDM9 is linked to breast carcinoma.